DocSym
β
Searchsearch
Search
(N03.5) Chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
More details coming soon
1 067 174 in individuals diagnosis chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis confirmed
34 272 deaths with diagnosis chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
3% mortality rate associated with the disease chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
Diagnosis chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis is diagnosed Men are 9.15% more likely than Women
582 411
Men receive the diagnosis chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
18 762 (3.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
484 763
Women receive the diagnosis chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
15 510 (3.2 %)Died from this diagnosis.
Risk Group for the Disease chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis - Men aged 55-59 and Women aged 15-19
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 0-1, 95+
In Women diagnosis is most often set at age 0-94
Disease Features chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
Absence or low individual and public risk
Chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis - what does this mean
Chronic nephritic syndrome is caused by diffuse mesangiocapillary glomerulonephritis, a type of glomerulonephritis in which the glomeruli of the kidney become inflamed and damaged. this causes the kidneys to become unable to filter out waste and excess fluid from the body, leading to a buildup of toxins in the blood and a decrease in the production of urine.
What happens during the disease - chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis
Chronic nephritic syndrome is caused by diffuse mesangiocapillary glomerulonephritis, a type of glomerulonephritis that affects the small blood vessels in the kidneys. it is characterized by inflammation of the glomeruli, the tiny filters inside the kidneys that are responsible for filtering the blood. this inflammation leads to an accumulation of proteins and red blood cells in the urine, as well as an increase in the amount of waste products that are not filtered out. over time, this can lead to permanent damage to the kidneys and a decline in their function.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Urine analysis
- Blood tests
- Imaging tests (e.g. ultrasound, CT scan, MRI)
- Kidney biopsy
- Renal function tests
- Renal ultrasound
- Renal angiogram
- Renal scintigraphy
Treatment and Medical Assistance
Main goal of the treatment: Reduce inflammation, prevent further damage to the glomeruli, and preserve kidney function.
- Prescription of corticosteroids or other immunosuppressants to reduce inflammation
- Blood pressure control using anti-hypertensive medications
- Prescription of medications to reduce proteinuria (protein in the urine)
- Dietary modifications to reduce salt and protein intake
- Fluid and electrolyte balance maintenance
- Regular monitoring of kidney function and urine protein levels
- Regular monitoring of blood pressure
- Regular monitoring of blood chemistry levels
- Regular monitoring of urinalysis results
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Chronic nephritic syndrome : diffuse mesangiocapillary glomerulonephritis - Prevention
The best way to prevent chronic nephritic syndrome is to maintain a healthy lifestyle, including eating a balanced diet, exercising regularly, avoiding smoking, and controlling blood pressure and cholesterol levels. additionally, it is important to get regular check-ups and to follow any advice given by your doctor to help prevent or manage any existing conditions that could lead to chronic nephritic syndrome.